Literature DB >> 15670742

The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability.

Vincent Brondani1, Quirino Schefer, François Hamy, Thomas Klimkait.   

Abstract

Peptidyl-prolyl isomerases (PPIase) facilitate the cis-trans interconversion of the peptidyl-prolyl bond and in such way affect protein folding. Pin1 is a PPIase, which specifically recognizes phosphorylated S/T-P bonds. The transcription factor TFIIH mediates phosphorylation of the retinoic acid receptor alpha (RARalpha) at position Ser77. In the presence of retinoic acid ligand (RA), the Ser77 non-phosphorylated receptor is suggested to undergo degradation through the proteasome pathway. Here we provide evidence that Pin1 is able to selectively destabilize RARalpha in a ligand independent-manner. We show that this is caused by RARalpha ubiquitination, which in turn is phosphorylation dependent. The single mutation Ser77>A completely abolishes RARalpha degradation whereas the mutation Ser77>E rescues this effect. In addition, we correlate RARalpha stability to Ser77 phosphorylation required for the ligand independent transcriptional activity on fgf8 promoter. Finally, we show that the ligand-independent Ser77 phosphorylation requires the genuine ligand-binding domain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670742     DOI: 10.1016/j.bbrc.2004.12.130

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Phosphorylation stabilizes Nanog by promoting its interaction with Pin1.

Authors:  Matteo Moretto-Zita; Hua Jin; Zhouxin Shen; Tongbiao Zhao; Steven P Briggs; Yang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-09       Impact factor: 11.205

2.  Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.

Authors:  Prashant Rajbhandari; Greg Finn; Natalia M Solodin; Kiran K Singarapu; Sarata C Sahu; John L Markley; Kelley J Kadunc; Stephanie J Ellison-Zelski; Anastasia Kariagina; Sandra Z Haslam; Kun Ping Lu; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

Review 3.  Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

4.  Androgen receptor serine 81 mediates Pin1 interaction and activity.

Authors:  Raffaele La Montagna; Isabella Caligiuri; Pasquale Maranta; Chiara Lucchetti; Luca Esposito; Marco G Paggi; Giuseppe Toffoli; Flavio Rizzolio; Antonio Giordano
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

5.  Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.

Authors:  Prashant Rajbhandari; Mary Szatkowski Ozers; Natalia M Solodin; Christopher L Warren; Elaine T Alarid
Journal:  J Biol Chem       Date:  2015-04-12       Impact factor: 5.157

Review 6.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Authors:  Yih-Cherng Liou; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2011-08-17       Impact factor: 13.807

7.  The prolyl isomerase Pin1 is overexpressed in human esophageal cancer.

Authors:  Huawei Jin; Jie Jiang; Lifang Sun; Fangfang Zheng; Chengyan Wu; Lin Peng; Yufen Zhao; Xueji Wu
Journal:  Oncol Lett       Date:  2011-08-23       Impact factor: 2.967

Review 8.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

Review 9.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

10.  Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.

Authors:  Vera Mugoni; Riccardo Panella; Giulia Cheloni; Ming Chen; Olga Pozdnyakova; Dina Stroopinsky; Jlenia Guarnerio; Emanuele Monteleone; Jonathan David Lee; Lourdes Mendez; Archita Venugopal Menon; Jon Christopher Aster; Andrew A Lane; Richard Maury Stone; Ilene Galinsky; José Cervera Zamora; Francesco Lo-Coco; Manoj Kumar Bhasin; David Avigan; Letizia Longo; John Gerard Clohessy; Pier Paolo Pandolfi
Journal:  Cell Res       Date:  2019-04-25       Impact factor: 46.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.